IRIS
PITINI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.140
EU - Europa 5.825
AS - Asia 2.814
SA - Sud America 1.007
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 91
OC - Oceania 6
Totale 16.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.996
RU - Federazione Russa 2.931
SG - Singapore 1.208
BR - Brasile 874
CN - Cina 840
IE - Irlanda 711
SE - Svezia 694
UA - Ucraina 344
HK - Hong Kong 313
DE - Germania 289
IT - Italia 196
GB - Regno Unito 183
FR - Francia 154
FI - Finlandia 150
VN - Vietnam 137
IN - India 63
BD - Bangladesh 51
CA - Canada 44
AR - Argentina 41
BE - Belgio 39
MX - Messico 31
IQ - Iraq 30
ZA - Sudafrica 28
TR - Turchia 25
PL - Polonia 24
NL - Olanda 23
EC - Ecuador 22
JP - Giappone 19
CZ - Repubblica Ceca 18
VE - Venezuela 18
AT - Austria 16
CO - Colombia 16
UZ - Uzbekistan 16
KE - Kenya 13
ES - Italia 12
MA - Marocco 12
PY - Paraguay 12
AZ - Azerbaigian 11
IL - Israele 11
TN - Tunisia 11
PK - Pakistan 10
TT - Trinidad e Tobago 10
CL - Cile 8
GT - Guatemala 8
PE - Perù 8
HN - Honduras 7
ID - Indonesia 7
IR - Iran 7
JM - Giamaica 7
NI - Nicaragua 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
LT - Lituania 6
OM - Oman 6
SA - Arabia Saudita 6
SC - Seychelles 6
SV - El Salvador 6
XK - ???statistics.table.value.countryCode.XK??? 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EG - Egitto 5
JO - Giordania 5
NP - Nepal 5
PA - Panama 5
AL - Albania 4
AM - Armenia 4
AU - Australia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CW - ???statistics.table.value.countryCode.CW??? 4
NO - Norvegia 4
PS - Palestinian Territory 4
BN - Brunei Darussalam 3
LB - Libano 3
LV - Lettonia 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
Totale 15.873
Salva come PNG Salva come JPEG
Città #
Ashburn 870
Moscow 788
Dublin 711
Singapore 677
Jacksonville 653
Chandler 567
Dallas 454
San Jose 407
Nyköping 358
Beijing 312
Hong Kong 311
Council Bluffs 216
Ann Arbor 156
The Dalles 141
Los Angeles 124
Princeton 123
Cambridge 120
Des Moines 101
Lauterbourg 100
Dearborn 93
Medford 86
Boardman 74
New York 72
Lancaster 61
São Paulo 60
Woodbridge 60
Munich 59
Messina 56
Buffalo 53
Tianjin 46
Ho Chi Minh City 41
Wilmington 39
Brussels 37
Guangzhou 36
Jinan 36
Santa Clara 36
Orem 32
Hanoi 29
Redondo Beach 29
Houston 28
Rio de Janeiro 27
Phoenix 26
Shenyang 26
Chicago 22
San Mateo 22
Seattle 22
Turku 22
Columbus 21
Warsaw 21
Atlanta 20
Belo Horizonte 19
Shanghai 18
Tokyo 18
Denver 17
Nanjing 17
Ningbo 17
Brno 16
Düsseldorf 16
Haikou 16
Brasília 15
Brooklyn 15
Chennai 15
Zhengzhou 15
Milan 14
Nanchang 14
Vienna 14
Auburn Hills 13
Frankfurt am Main 13
North Bergen 13
Stockholm 13
Taizhou 13
Tashkent 13
Baghdad 12
Goiânia 12
Hangzhou 12
Hebei 12
Quito 12
Rome 12
Salvador 12
San Francisco 12
Amsterdam 11
Baku 11
Curitiba 11
Johannesburg 11
Washington 11
Boston 10
Campinas 10
Montreal 10
Porto Alegre 10
Shenzhen 10
Buenos Aires 9
Dhaka 9
Hyderabad 9
Nairobi 9
Naples 9
Ribeirão Preto 9
Barnet 8
Bologna 8
Cape Town 8
Catania 8
Totale 9.102
Salva come PNG Salva come JPEG
Nome #
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. 246
Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience 244
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 224
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment. 218
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients. 211
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms 207
Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued? 203
An accessory spleen wrongly recognised as relapse by positron emission tomography 202
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report 199
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED OR REFRACTORY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE 198
An acute-leukaemia-like picture due to breast carcinoma cells. 193
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 192
AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 188
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow 188
Emerging markers of cachexia predict survival in cancer patients. 186
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas 184
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 184
Amifostine in conjuction with G-CSF enhances chemoterapy mobilization of peripheral blood progenitor cell 183
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 182
Trattamento endoscopico scleroterapico nelle neoplasie sanguinanti del tratto digestivo. 181
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST 179
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 175
ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE 175
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 173
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 172
Fatal delayed diagnosis in a patient with falciparum malaria 171
Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients 169
A sequential chemoimmunotherapy protocol can obtain a high proportion of molecular remission in chronic lymphocytic leukaemia 169
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward? 167
Endobronchial electrocautery for the dehydration of lung cancer. 165
AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS 162
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery 162
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma 160
CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA: CORRELATION WITH DISEASE STAGE 159
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 159
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 157
Thyroid function, autoimmunity and nodules in hematological malignancies 155
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases 154
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes 153
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 152
IMATINIB-INDUCED APOPTOSIS IN EOSINOPHILS OF PATIENTS WITH A HYPEREOSINOPHILIC SYNDROME PREDICTS RESPONSE TO TREATMENT 151
SUBCUTANEOUS LOW-DOSE ALEMTUZUMAB AS FIRST LINE THERAPY FOR ELDERLY CLL PATIENTS WITH DELETION OF 17p 148
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 147
Use of bisphosphonates in oncology 147
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report 146
How cells respond to interferons. 145
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 144
Circulating plasma cells in Multiple Myeloma: correlation with disease stage 143
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 142
Imatinib-induced apoptosis in the eosinophils of patients with a hypereosinophilic syndrome: A surrogate marker of response? 142
Temozolomide-induced shrinkage of a pituitary carcinoma. 141
Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient 137
MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST 137
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF 135
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 132
ADVERSE PROGNOSTIC FACTOR OF p53 GENE DELECTION DETECTED BY FISH IN MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION 131
Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma 131
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate 130
ANALISI SEQUENZIALE DELLA TRISOMIA 12 NELLA LEUCEMIA LINFATICA CRONICA 129
ALTE DOSI: QUESTIONI APERTE E SVILUPPI FUTURI 128
MORPHOLOGICAL, PHENOTYPIC AND KARYOTYPIC CHARACTERIZATION OF A NOVEL NATURAL-KILLER-CELL TARGET - EVIDENCE OF INVOLVEMENT OF MHC CLASS-I MOLECULES IN NK CELL RECOGNITION 127
Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy? 126
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease. 125
Resistance to PGE(2) inhibition of PWM-stimulated lymphocytes from neoplastic patients 125
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 124
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent 124
IMMUNOCHEMOTHERAPY WITH RITUXIMAB AND TEMOZOLOMIDE FOR CENTRAL NERVOUS SYSTEM LYMPHOMAS 123
Myeloid-derived suppressor cells absolute counts in predicting durable response to R-CHOP in patients with follicular lymphoma. 122
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 117
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study 115
DIABETIC FOOT DISEASE IN A PATIENT WITH MULTIPLE MYELOMA RECEIVING THALIDOMIDE 114
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 111
Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer 110
Circulating Mitotic Figures In A Patient With Dual Infection By Epstein-Barr Virus And Cytomegalovirus. 109
Pitfalls of positron emission tomography for assessing relapse in Hodgkin'sdisease: a case report 108
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence 102
Sequential treatment with alemtuzumab and rituximab can induce long-term responses in splenic marginal zone lymphoma 99
PIK3CA mutations in breast cancer: A potential predictive marker 99
Efficacy and safety of bortezomib in patients with plasma cell leukemia 99
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time. 99
null 99
GENE EXPRESSION PROFILING DOES NOT IDENTIFY MOLECULAR SUBGROUP AMONG NODAL PERIPHERAL T-CELL LYMPHOMAS 97
THALIDOMIDE IN COMBINATION WITH DCEP OVERCOMES VAD CHEMORESISTENCE AND ALLOWS PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS 97
Personalized treatment of early-stage non-small-cell lung cancer: The challenging role of EGFR inhibitors 97
SUCCESSFULL MOBILIZATION OF PERIPHERAL PROGENITOR CELLS WITH PACLITAXEL AND LENOGRASTIM PATIENTS WITH METASTATIC BREAST CANCER 96
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKIN'S DISEASE 95
Risk of second malignant neoplasm among patients with lymphoma 95
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 95
ERYTHROPOIETIN IN CONJUNCTION WITH H.D. VP16 AND LENOGRASTIM ENABLE PBPC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 94
IMPIEGO DELLA AMIFOSTINE+HD VP16+G-CSF NEI PAZIENTI CON MIELOMA MULTIPLO CHE NON MOBILIZZANO DOPO CTX+G-CSF 93
RESPONSE TO IMATINIB IN CHRONIC MYELOPROLIFERATIVE DISEASES WITH ACTIVATION OF THE PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR (PDGF betaR) 93
Uso di Bortezomib come terapia di prima linea nella leucemia plasmacellulare primaria 93
Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab 92
Single-dose of pegfilgrastim after chemotherapy is sufficient for mobilization of peripheral blood stem cells in patients with multiple myeloma 91
IMPIEGO DELLA AMIFOSTINA NELLE PROCEDURE DI MOBILIZZAZIONE. NOSTRA ESPERIENZA 91
Immunochemotherapy with temozolomide and rituximab for central nervous system lymphomas in an elderly population. 91
LIMITATIONS OF MOLECULAR DETECTION OF CK19 mRNA-POSITIVE CELLS IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS WITH HISTOLOGICALLY NEGATIVE AXILLARY LYMPH NODES 91
Preliminary results of a phase II study of amifostine for patients with myelodisplastic syndrome 91
null 90
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate. 89
Totale 14.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022685 0 0 0 17 25 3 58 27 5 160 154 236
2022/20232.164 173 209 102 170 187 205 23 136 855 9 71 24
2023/2024445 38 88 29 57 28 83 14 34 3 22 3 46
2024/20252.370 28 34 31 145 106 71 33 597 606 156 183 380
2025/20266.586 325 390 478 362 535 1.460 878 787 897 252 97 125
2026/20271.019 109 242 298 370 0 0 0 0 0 0 0 0
Totale 16.024